Monterey Bio Acquisition Corporation
MTRY · NASDAQ
6/30/2023 | 3/31/2023 | 12/31/2022 | 9/30/2022 | |
|---|---|---|---|---|
| Market Cap | $53 | $52 | $51 | $143 |
| - Cash | $1 | $0 | $0 | $1 |
| + Debt | $2 | $1 | $0 | $0 |
| Enterprise Value | $55 | $53 | $51 | $143 |
| Revenue | $0 | $0 | $0 | $0 |
| % Growth | – | – | – | – |
| Gross Profit | $0 | -$0 | -$2 | -$1 |
| % Margin | – | – | – | – |
| EBITDA | -$0 | -$0 | -$0 | -$1 |
| % Margin | – | – | – | – |
| Net Income | -$0 | -$0 | -$0 | -$0 |
| % Margin | – | – | – | – |
| EPS Diluted | -0.031 | -0.031 | -0.063 | -0.03 |
| % Growth | 0.3% | 50.4% | -111.1% | – |
| Operating Cash Flow | -$0 | -$0 | -$0 | -$0 |
| Capital Expenditures | $0 | $0 | $0 | $0 |
| Free Cash Flow | -$0 | -$0 | -$0 | -$0 |